Literature DB >> 23702159

Is type 2 diabetes really a coronary heart disease risk equivalent?

Christoph H Saely1, Heinz Drexel.   

Abstract

The concept of diabetes as a coronary heart risk (CHD) equivalent postulates that patients with diabetes who do not yet have CHD are at an equally high cardiovascular risk as non-diabetic patients with CHD. This implies important therapeutic, psychological, and economical consequences. However, whereas several reports support the concept of diabetes as a CHD risk equivalent, others refute it, and several investigations find that the cardiovascular risk conferred by diabetes is strongly modulated by sex (with diabetes conferring a greater risk increase in women), diabetes duration, concomitant risk factors, or the presence of subclinical atherosclerosis. A detailed review of the literature shows that the concept of diabetes as a CHD risk equivalent is overly simplistic, because not all patients with diabetes are at the same cardiovascular risk. An individualized approach to cardiovascular risk estimation and management appears mandatory in patients with diabetes.
Copyright © 2013 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Cardiovascular disease; Coronary artery disease; Coronary heart disease; Coronary heart disease risk equivalent; Diabetes mellitus

Mesh:

Year:  2013        PMID: 23702159     DOI: 10.1016/j.vph.2013.05.003

Source DB:  PubMed          Journal:  Vascul Pharmacol        ISSN: 1537-1891            Impact factor:   5.773


  9 in total

Review 1.  Dyslipidemia in diabetes mellitus and cardiovascular disease.

Authors:  Haider J Warraich; Jamal S Rana
Journal:  Cardiovasc Endocrinol       Date:  2017-02-15

Review 2.  Role for combination therapy in diabetic dyslipidemia.

Authors:  Haider J Warraich; Nathan D Wong; Jamal S Rana
Journal:  Curr Cardiol Rep       Date:  2015-05       Impact factor: 2.931

3.  [Lipid lowering therapy in geriatric patients].

Authors:  M Lechleitner
Journal:  Z Gerontol Geriatr       Date:  2013-08       Impact factor: 1.281

Review 4.  Assessment of cardiovascular risk in diabetes: Risk scores and provocative testing.

Authors:  Teresa Lam; Kharis Burns; Mark Dennis; N Wah Cheung; Jenny E Gunton
Journal:  World J Diabetes       Date:  2015-05-15

Review 5.  Extreme Atherosclerotic Cardiovascular Disease (ASCVD) Risk Recognition.

Authors:  Paul D Rosenblit
Journal:  Curr Diab Rep       Date:  2019-07-22       Impact factor: 4.810

6.  Effect of E670G Polymorphism in PCSK9 Gene on the Risk and Severity of Coronary Heart Disease and Ischemic Stroke in a Tunisian Cohort.

Authors:  Afef Slimani; Yahia Harira; Imen Trabelsi; Walid Jomaa; Faouzi Maatouk; Khaldoun Ben Hamda; Mohamed Naceur Slimane
Journal:  J Mol Neurosci       Date:  2014-03-06       Impact factor: 3.444

7.  The Population-Based Risk of Need for Coronary Revascularization According to the Presence of Type 2 Diabetes Mellitus and History of Coronary Heart Disease in the Korean Population.

Authors:  Chang Hee Jung; Gi Hyeon Seo; Sunghwan Suh; Ji Cheol Bae; Mee Kyoung Kim; You-Cheol Hwang; Jae Hyeon Kim; Byung-Wan Lee
Journal:  PLoS One       Date:  2015-06-08       Impact factor: 3.240

8.  Different levels of glycosylated hemoglobin influence severity and long-term prognosis of coronary heart disease patients with stent implantation.

Authors:  Jing Wang; Gaoliang Yan; Yong Qiao; Dong Wang; Genshan Ma; Chengchun Tang
Journal:  Exp Ther Med       Date:  2014-12-11       Impact factor: 2.447

9.  Comparison of Novel Martin/Hopkins and Sampson Equations for Calculation of Low-Density Lipoprotein Cholesterol in Diabetic Patients.

Authors:  Abdulrahman Naser; Khagani Isgandarov; Tolga Sinan Güvenç; Rengin Çetin Güvenç; Müslüm Şahin
Journal:  Arq Bras Cardiol       Date:  2022-08       Impact factor: 2.667

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.